Deletion of the long arm of human chromosome 6 in acute lymband; 14 
Introduction

Patients and methods
Two main different genetic alterations are involved in tumor
Patients initiation and/or progression, oncogene activation and tumorsuppressor gene (TSG) inactivation. Recent studies have sugPatients with ALL aged from 2 to 14 years were studied (99 gested the importance of TSG in leukemia 1,2 but, until now, B-lineage ALL and 21 T-lineage ALL). ALLs were classified on only a few such genes have been implicated in these tumors.
the basis of lymphoid morphology and immunophenotype as Inactivation of both alleles of a TSG may occur through a assessed by flow cytometry. ALL were defined as belonging combination of various molecular mechanisms including to the T-lineage, based on the presence of at least two of the point mutations, deletions, chromosomal rearrangements or T cell antigens CD2, CD5 and CD7. The diagnosis of B-prepromoter inactivation. However, the usual strategy for localizcursor ALL was based on the expression of B cell-associated ing a TSG is to search for recurrent deletions in cancer cells. 3 
antigens (CD19
+ , CD22 ± , CD10 ± ) and the lack of surface In childhood acute lymphoblastic leukemia (ALL), chromomembrane immunoglobulins. Karyotype studies were systemsomal regions of non-random deletions have been previously atically performed at presentation. Informed consent was found by cytogenetics 4 and allelotype studies. 2 These studies obtained from the patients or their parents, or both, as approidentified several such regions on the 9p, 12p, 13q and 6q priate. chromosomal arms. The MTS1 gene [5] [6] [7] and the TEL gene 8 have been found to be targets of deletions in a majority of cases involving the 9p and 12p chromosomal arms, respectSample collection ively, and several candidate genes are currently being studied in the 13q14 chromosomal band. 9, 10 In contrast, little is Bone marrow (BM) was collected in EDTA before inducation known about the critical region involved in the 6q deletions.
therapy and during clinical remission according to the EORTC Cytogenetic deletions of the 6q chromosomal arm are found 58 881 follow-up protocol. At the time of diagnosis, all studin 4-11% of ALLs.
11-14 Deletions involving the long arm of ied samples contained up to 70% blasts, as determined by chromosome 6 also occur in other hematopoietic maligcytology. nancies such as non-Hodgkin lymphoma (NHL) [15] [16] [17] [18] [19] [20] and in a wide variety of tumors including ovarian tumor, 21 ,22 breast cancer 23 and melanoma. 24 Moreover, suppression of tumoriPreparation of mononuclear cell lysates genicity of different cell lines has been observed when a normal chromosome 6 was introduced. 25, 26 Mononuclear cells were separated by gradient centrifugation Compilation of published data give conflicting results conover Ficoll (Lymphoprep, Pharmacia, Uppsala, Sweden), cerning the localization of the common region of 6q deletions washed in a 9 g/l NaCl solution, counted, and stored at in ALL: a first cytogenetic study of 38 cases with 6q deletions −160°C. Erythrocytes were lysed in a solution containing localized a commonly deleted region encompassing the 6q21 10 mmol/l Tris-HCl pH 7.5, 1% Triton-100 (Sigma, St Louis, MO, USA), 5 mmol/l MgCl 2 . Mononuclear cells were then incubated for 2 h at 60°C in a buffer containing 0.45% Nonidet-P40 (Sigma), 2.5 mmol/l MgCl 2 , 10 mmol/l Tris-HCl pH to obtain a concentration of 6 ng of DNA per l and stored were amplified using the non-fluorescent primer procedure and PCR products were visualized on a 2% agarose gel at −20°C.
stained with ethidium bromide.
Polymorphic markers
Results
The markers used in this study and their cytogenetic location were: f-D6S286 (6q14-15); f-D6S300, D6S1671, f-D6S468 Loss of heterozygosity mapping (6q16.3-21); f-D6S283, D6S434, f-D6S301, D6S1592, f-D6S447, D6S268, D6S278, D6S1594, D6S1698, f-D6S261
To determine the localization of allelic deletions on the long arm of chromosome 6 in childhood ALL, polymorphic mark-(6q21-23.2); D6S401, D6S1639, D6S407, D6S1620, f-D6S270 (6q22.3-23.2); f-D6S305 (6q25-27), f-D6S446 (6qter) ers spanning 6q were analyzed by PCR. Results obtained with blast DNA were compared with corresponding matched nor-(f-means that one of the primers was labeled with fluorescein). The relative order of the markers and primer mal cells from each patient. Since LOH frequently appears as a decrease rather than a total disappearance of the lost allele sequences were obtained from the Whitehead Institute/MIT Center for Genome Research.
because of the persistence of 1-30% normal marrow cells in blast samples, a quantitative assay was required to accurately discriminate a deletion from a trisomy. In this study, quantification of the peaks was performed using a fluorescent autoGenotyping using fluorescent primers mated laser DNA sequencer, and a relative ratio [tumor cells/somatic cells] was calculated (see the Patients and Polymerase chain reaction (PCR) was performed using a 5′ fluorescein-labeled primer. The PCR mixture contained methods section). Typical results are shown in Figure 1 . When both alleles were present in blasts, the allelic ratio was close 10 mmol/l Tris-HCl pH 9.0, 50 mmol/l KCl, 0.1% Triton, 0.2 g/l gelatin, 100 mol/l of each dNTP, 1.5 mmol/l MgCl 2 , to 1. Samples were considered to have undergone LOH when ratios were less than 0.3. In patients with trisomy 6 detected 20 pmol of each primer and 5 l of the cell lysate in a final volume of 50 l. After 10 min at 96°C, 0.25 U of Taq polyby cytogenetics, ratios of 0.4-0.7 were observed for all the markers tested. Therefore, patients displaying a ratio between merase (Appligene, Strasbourg, France) was added. Then 35 cycles were performed as follows: 40 s at 94°C and 30 s at 0.4 and 0.7 were considered as having trisomy 6. We first scanned the 6q arm from 6q14-15 to the 6q telo-55°C. After denaturation, the PCR products were analyzed using a fluorescent automated laser DNA sequencer (ALF; mere using seven polymorphic markers in 81 children with ALL (f-D6S286, 6q14-15; f-D6S300 and f-D6S468, 6q16.3-21; Pharmacia, Uppsala, Sweden). Electrophoresis was performed on a 6% long-ranger gel (Bioprobe, Paris, France) containing f-D6S261, 6q21-23.2; f-D6S270, 6q22.3-23.2; f-D6S305, 6q25.2-27; f-D6S446, 6qter). Five patients displayed LOH for 8 mol/l urea in a 0.6X Tris-borate-EDTA buffer. Areas under the curve of the peaks were determined using the software at least one marker. Comparison of the results obtained from these patients defined a common region of LOH ( overlap (SRO) of the deletions we further studied the same series of 81 patients using 14 additional polymorphic markers located between D6S300 and D6S270. We detected one
Genotyping using non-fluorescent primers additional patient with LOH and the SRO was reduced to a 6 cM interval flanked by two markers, D6S1594 on the telo-PCR was performed in a final volume of 50 l containing 60 ng of genomic DNA, 50 pmol of each primer, 125 m/l of meric side and D6S301 on the centromeric side ( Figure 2 ). All the patients that displayed LOH had a single region of each dNTP, 1.5 mmol/l MgCl 2 , 50 mmol/l Tris-HCl pH 8.3. After 10 min at 96°C, 1 U of Taq polymerase (Perkin-Elmer, deletion. Foster City, CA, USA) was added and 35 cycles were performed as described above. After PCR, eight amplification products of each DNA sample were pooled, precipitated and migrated in a single lane of a 6% polyacrylamide gel containing 8 mol/l urea. Then, PCR products were blotted onto a Hybond N+ membrane (Amersham, Buckinghamshire, UK) and eight successive hybridizations with a 5′ 32 P-radiolabeled primer were performed on each membrane.
Leukemia cell lines K562, HEL, CML, Molt-3, Nalm-6, Daudi, Raji, 697, REH and MKB1 leukemia cell lines were obtained from DMS (Braunschweig, Germany). They were grown according to the manufacturer's recommendations and cell lysis was perfor- Raji, 697, REH, MKB1), two of which have one 6q arm deletion (Molt-3 and 697). None of eight markers located in the SRO that we studied was homozygously deleted.
Discussion
The occurrence of non-random deletions of the long arm of chromosome 6 has been observed in lymphoid malignancies. In ALL, 6q deletions have been observed in 4-11% of cases but previous studies have reported conflicting data on the putative region of overlap and on the number of regions involved. 1, 14, 27 To determine the implication of the 6q deletion in leukemogenesis, we mapped the loss of heterozygosity of the 6q arm in children with ALL.
First, we studied seven highly polymorphic markers extending from 6q14-15 to the 6q telomere in 81 children with ALL. We found that there was a single commonly deleted region flanked by D6S300 (6q16.3-21) and D6S270 (6q22.3-23.2). Thus, no deletion specifically involved the 6q25-27 chromosomal band, a region of deletion that has been previously identified in NHL 1, 15, 17, 19 and in solid tumors such as ovarian tumor, breast cancer and melanoma. [21] [22] [23] [24] To narrow down the region of common deletion, we studied 14 additional polymorphic markers and defined a 6 cM region of overlap between markers D6S301 and D6S1594, approximately located at the 6q21-22 chromosomal band. This localization is in agreement with two previous reports: in childhood ALL, a common region of deletion at chromosomal band 6q21 was found by cytogenetic studies of 38 patients with 6q deletions; 14 moreover, FISH analysis of six other cases of childhood defined a common region of deletion between the M6P1 locus in the 6q14-6q15 chromosomal region and the 
4). To specify further the frequency of 6q deletions in childhood
In our series, the overall frequency of LOH in the common ALL, we studied a second series of 39 patients using three region of deletion was 6.7% (6.1% in B-lineage ALL and 9.5% markers located within the critical region (D6S301, D6S447 in T-ALL). Although these frequencies are not very high, they and D6S1594). We detected two additional patients with a are likely to indicate the presence of a TSG in the 6q21 6q deletion. The overall frequency of 6q deletions was 6.7% chromosomal region whose deletion may contribute to leuke-(8/120), with 6.1% in B-lineage ALL (6/99) and 9.5% in mogenesis in a significant proportion of childhood ALLs. T-lineage ALL (2/21).
Indeed, previous studies using random markers have shown In 20 patients (16.7%), we observed an allelic ratio close that the rate of LOH at most of the loci is very low in this type to 0.5 that suggested the presence of trisomy 6. In all these of malignancy in contrast with the usual observation of a high cases but one, all the markers tested displayed a similar allelic rate of random loss in solid tumors. 2, 28 The observation of a imbalance. In 10 patients a hyperdiploid karyotype (Ͼ50 region of deletion shared by all the eight patients with LOH chromosomes with a standard pattern of chromosome gains) in the 6q chromosomal arm also argues for the non-random was observed, in seven cases the karyotype could not be nature of these deletions. The rate of 6q deletion detected by established and in three cases the karyotype was apparently LOH in the present study is close to those previously reported normal. In one case, with normal karyotype, allelic imbalance in cytogenetic studies 11-14 although in 5/8 cases reported here, involved one 6q chromosomal portion located between LOH could not be anticipated from the karyotype. This may D6S468 (6q16. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] and D6S261 (6q21-22.3); this may indiappear surprising since LOH studies using closely spaced cate either that there is a partial duplication of the 6q arm markers have the potential to detect small deletions that or that the blast population is heterogeneous with one subare not visible on the karyotype. For example, such an population with an interstitial 6q deletion and another with approach revealed a frequency of 12p deletions at least two normal chromosomes 6.
four times higher than previously suspected from cytogenetic studies. [29] [30] [31] In the present study, the smallest 6q deletion detected in our patients was flanked by two markers separated Search for homozygous deletions in leukemic cells by 10 cM. The low frequency or absence of small deletions lines makes it difficult to narrow down the region of interest by LOH mapping. In order to search for homozygous deletions In order to look for homozygous deletions we studied 10 leukemic cell lines (K562, HEL, CML, Molt-3, Nalm-6, Daudi, that could be involved in TSG inactivation, we studied eight 
